Tian et al. [26] reported that TRPM2-AS promoted BLCA by targeting miR-22-3p and regulating the expression of GINS2. Qin et al. [27] revealed that high LINC01605 expression promoted BLCA progression by upregulating MMP9. Here, GINS2 is linked to bladder transitional cell carcinoma.